Md Rahim
FDA investigator
Appears on 1 document from 2024, mostly at sites in Lithuania. Most often cites general requirements (21 CFR 211.160).
- 1
- Documents on file
- 8.0
- Observations per 483
- 2024
- First seen
- 2024
- Most recent
What they cite most
From 8 observations- 21 CFR 211.160General requirements2
- 21 CFR 211.192Production record review2
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.67Equipment cleaning and maintenance1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
Activity by year
2024: 1
Where
Lithuania 1
Often inspects with
Is Md Rahim coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-01-31 | 483 BIOTECHPHARMA BIOTECHNOLOGINES FARMACIJOS CENTRAS UABJan 31, 2024 · Vilnius, Lithuania | Vilnius, Lithuania | 8 |
About this profile
What does Md Rahim inspect?
Md Rahim appears on 1 document on file covering 1 site, mostly in Lithuania.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.192 and 21 CFR 211.42.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Md Rahim is dated Jan 31, 2024.